Financhill
Sell
18

BDRX Quote, Financials, Valuation and Earnings

Last price:
$2.32
Seasonality move :
-31.85%
Day range:
$2.00 - $2.11
52-week range:
$1.84 - $74.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.82x
P/B ratio:
0.12x
Volume:
63.1K
Avg. volume:
1.8M
1-year change:
-92.93%
Market cap:
$1.3M
Revenue:
$474.1K
EPS (TTM):
-$74.60

Earnings Data

Next earnings date for BDRX
Apr 18
2025
Most recent earnings per share
--
Missed by --
(Dec 31/2018)
Consensus Estimate
--
(Dec 31/2018)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BDRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2019 Q2 -- -- -- -$208.17 --
03/31/2019 Q1 -- -- -- -$104.09 --
12/31/2018 Q4 -- -- -- -- --
09/30/2018 Q3 -- -- -- -$5,107.44 --
06/30/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -$7,794.30 --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -$6,395.04 --
06/30/2017 Q2 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
06/30/2016 Q2 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --

Biodexa Pharmaceuticals PLC Earnings Questions

  • How Much did Biodexa Pharmaceuticals PLC Generate in Revenue Last Quarter?

    Biodexa Pharmaceuticals PLC reported -- worth of top line sales in its most recent quarter.

  • Did Biodexa Pharmaceuticals PLC Beat Earnings Last Quarter?

    Biodexa Pharmaceuticals PLC announced earnings per share of -- which represents a miss of analyst forecast a -- per share.

  • Is Biodexa Pharmaceuticals PLC Profitable?

    Biodexa Pharmaceuticals PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Biodexa Pharmaceuticals PLC EPS Next Year?

    Biodexa Pharmaceuticals PLC's earnings are forecast to decrease from -$248.86 per share to -$0.06 per share next year representing a decrease of -99.98%.

  • When is Biodexa Pharmaceuticals PLC's Earnings Date?

    Biodexa Pharmaceuticals PLC's next earnings date is April 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 5.74% over the past day.

Buy
93
ESLT alert for Mar 19

Elbit Systems [ESLT] is up 0.57% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock